The expression of AGPAT2, an enzyme involved in the glycerophospholipid/triacylglycerol biosynthesis pathway, has been suggested to promote survival and etoposide resistance of cancer cells, and to be directly involved in LD formation [52]. The gene discussed is AGPAT2; the disease is cancer.